Cargando…

Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers

Detalles Bibliográficos
Autores principales: Dietsch, Greg, Whiting, Sam, Northfelt, Donald, Ramanathan, Ramesh, Cohen, Peter, Manjarrez, Kristi, Newkirk, Mona, Bryan, James Kyle, Hershberg, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288547/
http://dx.doi.org/10.1186/2051-1426-2-S3-P165
_version_ 1782351986490867712
author Dietsch, Greg
Whiting, Sam
Northfelt, Donald
Ramanathan, Ramesh
Cohen, Peter
Manjarrez, Kristi
Newkirk, Mona
Bryan, James Kyle
Hershberg, Robert
author_facet Dietsch, Greg
Whiting, Sam
Northfelt, Donald
Ramanathan, Ramesh
Cohen, Peter
Manjarrez, Kristi
Newkirk, Mona
Bryan, James Kyle
Hershberg, Robert
author_sort Dietsch, Greg
collection PubMed
description
format Online
Article
Text
id pubmed-4288547
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42885472015-01-15 Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers Dietsch, Greg Whiting, Sam Northfelt, Donald Ramanathan, Ramesh Cohen, Peter Manjarrez, Kristi Newkirk, Mona Bryan, James Kyle Hershberg, Robert J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288547/ http://dx.doi.org/10.1186/2051-1426-2-S3-P165 Text en Copyright © 2014 Dietsch et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Dietsch, Greg
Whiting, Sam
Northfelt, Donald
Ramanathan, Ramesh
Cohen, Peter
Manjarrez, Kristi
Newkirk, Mona
Bryan, James Kyle
Hershberg, Robert
Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
title Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
title_full Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
title_fullStr Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
title_full_unstemmed Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
title_short Comparison of immune modulation by TLR8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
title_sort comparison of immune modulation by tlr8 agonist vtx-2337 (motolimod) in cancer patients and healthy volunteers
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288547/
http://dx.doi.org/10.1186/2051-1426-2-S3-P165
work_keys_str_mv AT dietschgreg comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers
AT whitingsam comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers
AT northfeltdonald comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers
AT ramanathanramesh comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers
AT cohenpeter comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers
AT manjarrezkristi comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers
AT newkirkmona comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers
AT bryanjameskyle comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers
AT hershbergrobert comparisonofimmunemodulationbytlr8agonistvtx2337motolimodincancerpatientsandhealthyvolunteers